Abstract:Background Damage to the coronary arteries during the acute phase of Kawasaki disease (KD) is linked to inflammatory cell infiltration, myointimal proliferation, and endothelial cell (EC) dysfunction. To understand the response of ECs to KD treatment, we studied the genome‐wide transcriptional changes in cultured ECs incubated with KD sera before and after treatment with or without atorvastatin. Methods and Results RNA sequencing of human umbilical vein ECs incubated with pooled sera from patients with acute KD before or after treatment with intravenous immunoglobulin and infliximab revealed differentially expressed genes in interleukin‐1, tumor necrosis factor‐α, and inflammatory cell recruitment pathways. Subacute sera pooled from patients treated with intravenous immunoglobulin, infliximab, and atorvastatin uniquely induced expression of NOS3 , Kruppel like factor ( KLF2 , and KLF4 (promotes EC homeostasis and angiogenesis) and ZFP36 ring finger protein (ZFP36) and suppressor of cytokine signaling 3 (SOCS3) (suppresses inflammation), and suppressed expression of TGFB2 and DKK1 (induces endothelial‐mesenchymal transition) and sphingosine kinase 1 (SPHK1) and C‐X‐C motif chemokine ligand 8 (CXCL8) (induces inflammation). Conclusions These results suggest that atorvastatin treatment of patients with acute KD may improve EC health, reduce mediators of inflammation produced by ECs, and block KD‐induced myofibroblast proliferation. Nonstandard Abbreviations and Acronyms CA coronary artery DEG differentially expressed gene EC endothelial cell EndMT endothelial‐to‐mesenchymal transition HUVEC human umbilical vein endothelial cell KD Kawasaki disease NOS NO synthase RT‐PCR reverse transcriptase–polymerase chain reaction TGF‐β transforming growth factor‐β Clinical Perspective What Is New? Analyzing the gene expression profile of cultured endothelial cells incubated with sera from patients who received different treatments provides a window into the vascular effects of those treatments. Endothelial cells incubated with serum from patients with acute Kawasaki disease treated with standard therapy plus atorvastatin showed gene expression profiles with improved endothelial cell health and decreased inflammation compared with controls. What Are the Clinical Implications? Although the American Heart Association guidelines encourage adjunctive therapy for patients with acute Kawasaki disease with early echocardiographic signs of coronary artery damage, there are currently no clinical trial data to guide best practice to stop the progression of arterial wall damage and prevent coronary artery aneurysm formation during the acute phase of Kawasaki disease. We demonstrated deleterious changes in endothelial cell transcriptional profiles that were mitigated by exposure to sera from patients treated with atorvastatin. The anti‐inflammatory and endothelial‐protective effects of atorvastatin may yield benefit in blocking coronary artery aneurysm progression in patients with Kawasaki disease when added to standard therapy. Acute systemic inflammation associated with Kawasaki disease (KD) induces coronary artery (CA) aneurysms in a subset of genetically susceptible children. Early in the acute phase of this vasculitis, neutrophils adhere to activated endothelial cells (ECs) and enter the arterial wall. 1 Cytotoxic T cells follow and mediate further arterial damage, resulting in focal weakening and aneurysm formation. 2 Endothelial‐to‐mesenchymal transition (EndMT), a process that transforms ECs into myofibroblasts, can result in remodeling of the arterial wall with myointimal proliferation and stenosis of the arterial lumen. 3 , 4 Stenoses commonly occur at the inlet or outlet of the an -Abstract Truncated-

Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-like Vasculitis Mouse Model

Statin suppresses the development of excessive intimal proliferation in a Kawasaki disease mouse model

Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis

The Activation of CaN/NFAT Signaling Pathway in Macrophages Aggravated Lactobacillus Casei Cell Wall Extract-Induced Kawasaki Disease Vasculitis.

Targeting The Sirt1 Pathway To Modulate Inflammation In A Murine Model Of Kawasaki Disease Vasculitis

RNA Sequencing Reveals Beneficial Effects of Atorvastatin on Endothelial Cells in Acute Kawasaki Disease

The role of Ca 2+ /NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease

Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway

Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease

Human adipose tissue-derived stem cells inhibit coronary artery vasculitis in a mouse model of Kawasaki disease

Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis

Abstract 13032: Endothelial Cell Response to Intravenous Immunoglobulin, Infliximab and Atorvastatin Treatment During the Acute Phase of Kawasaki Disease

Candesartan Attenuates Vasculitis in a Mouse Model of Kawasaki Disease Induced by Candida albicans Water-Soluble Fraction

Inhibition of IL-1 Ameliorates Cardiac Dysfunction and Arrhythmias in a Murine Model of Kawasaki Disease

Long-term cardiovascular inflammation and fibrosis in a murine model of vasculitis induced by Lactobacillus casei cell wall extract

A pathological study on the efficacy of Syk inhibitors in a Candida albicans-induced aortic root vasculitis murine model

Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence

Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome

Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis

Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis

Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats